London, United Kingdom

David Anthony Hughes

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cancer Research Campaign Technology Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Anthony Hughes. Retrieved from https://idiyas.com/inventor/david-anthony-hughes-gbflgfd2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Anthony Hughes: Innovator in Therapeutic Screening

Introduction

David Anthony Hughes is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic activity screening. His innovative work has led to the development of methods that enhance the understanding of substances used in therapy.

Latest Patents

David holds a patent for "Methods for screening of substances for therapeutic activity and yeast." This patent reflects his commitment to advancing medical research and improving therapeutic outcomes.

Career Highlights

David is associated with Cancer Research Campaign Technology Limited, where he applies his expertise to further cancer research and technology. His work is pivotal in the ongoing fight against cancer, contributing to the development of new therapeutic methods.

Collaborations

David has collaborated with esteemed colleagues such as Christopher John Marshall and Alan Ashworth. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

David Anthony Hughes is a dedicated inventor whose work in therapeutic screening is making a difference in cancer research. His contributions are vital to the advancement of medical science and the development of effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…